Furthermore, CMTM6 was shown to drive the formation of the M2a malignant macrophage phenotype, this dual role suggests that CMTM6 promotes oncogenesis by both facilitating TAM recruitment and reprogramming macrophages, making it a promising target for cancer therapy. Here, CMTM6 is linked to cancer.